Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOPP.L Regulatory News (OPP)

  • There is currently no data for OPP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Halosource

18 Jul 2008 12:30

RNS Number : 3995Z
Origo Sino-India PLC
18 July 2008
 



18 July 2008

Origo Sino-India PLC

Investment in HaloSource

Origo Sino-India Plc ("Origo" or the "Company") (LSE: OSI) is pleased to announce a new investment in conjunction with Origo Resource Partners Limited ("ORP" or "the Fund"), in HaloSource, Inc. ("HaloSource" or "the group"), a clean technology group focused on water treatment and anti microbial fabric treatment. 

Origo and ORP have entered into an agreement to acquire a combined equity stake of approximately 11% (on a fully diluted basis) in HaloSource for an investment of US$10 million, through the issue of new HaloSource sharesOrigo and ORP will also, as part of the investment, receive warrants on a 1 for 4 basis, to subscribe for further equity at the subscription price. The investment, which is being satisfied through the respective existing cash resources of OSI and ORP, will be split on a 30:70 basis between the Company and the Fund in accordance with the pre-existing co-investment agreement between the two entitiesOrigo and ORP are joined in this funding round by existing investors, including Unilever Technology Ventures, a fund managed by Physic Ventures. Under the terms of the agreement, Origo and ORP will together be entitled to appoint one director to the board of HaloSource.

Founded in 1998, HaloSource has invented, developed and commercialised technologies used in water purification, water clarification and antimicrobial textile coatings used to kill germs and viruses on towelling, bed linen and clothing.   Based on technology developed at Auburn University and the University of California, HaloSource has a strong base of intellectual property and know-how, with over 100 global patents granted or pending.  HaloSource has its head quarters in Seattle with manufacturing facilities in Raymond (near Seattle), Bangalore and a newly commissioned factory in Shanghai  HaloSource's products are branded and trademarked and the group has a rapidly growing customer list drawn from leading global businesses.

For the year ended 31 December 2007, HaloSource reported a revenue increase from continuing operations of 30%, generated through organic growth. During this development period Halosource did not generate a net profit. The group's highest growth revenue stream is based on water purification at point of use, at a price point which makes the technology available to lower income households in geographies such as China and India - where a shortage of drinking water and water related diseases are serious health issues. Origo intends to assist HaloSource, specifically in extending channels to market and advising on operational issues in these territories. The directors of Origo believe HaloSource's proven business model and management team will enable it to grow significantly as demand for its three distinct businesses increases throughout the developing and the developed world. 

The transaction is subject to normal closing conditions for a transaction of this type and is expected to complete later this month.

Commenting on today's announcement Chris Rynning, CEO of Origo, said:

"We continue to identify opportunities across a series of fast-growing sectors including the water purification & treatment industry, which will help to meet rapidly growing demand in China and India."

"Our investment in HaloSource underlines our focus on working with fast-growing companies where our business development expertise can help to bring about a step change in performance. We look forward to working with the highly experienced management team that HaloSource has assembled to capture the significant growth opportunities available."

ENDS

Further information:

Origo Sino-India PLC

Chris Rynning 

chris@origoplc.com

+86 1390 124 6417

Nominated Adviser: 

Smith & Williamson Corporate Finance Limited

Azhic Basirov

+44 (0)20 7131 4000 

Broker: 

Liberum Capital Limited

Simon Atkinson 

+44 (0)20 3100 2223

Public Relations:

Aura Financial

Michael Oke/Andy Mills

+44 (0)20 7321 0000

Notes to editors:

HaloSource 

HaloSource has three businesses, each with distinct brands:

"HaloPure" - kills all germs and bacteria to provide safe drinking water. Aimed at both developing and developed economies in a variety of applications. 

"SeaKlear" - provides germ-free, clear water for swimming pools, water parks and other recreational water environments - and "StormKlear" cleaning of industrial and storm water.

"HaloShield" - an enabling germ and virus-killing technology that has application on toweling products, applications in medical textiles, and military applications. 

Origo Sino-India PLC ("Origo"): 

Origo is an established private equity investor and strategic consultancy business, which provides its shareholders with exposure to growth opportunities and private equity returns in China and India

Origo's business model is to generate capital gains from private equity investment in growth companies from which it also generates fees for consultancy services related to further fundraisings, M&A and strategic development. 

 

Origo is aligned with two major financial institutions which provide a source of high quality deal flow. In China, Origo works closely with China Equity, a leading private equity firm, whose chief executive is a member of Origo's board. In India, Origo has entered into a memorandum of understanding with SBI Capital Markets, one of the longest established companies in the Indian Capital Markets. A former chairman of the State Bank of India is also a member of the board of Origo. 

Origo also signed a memorandum of understanding with GLG Partners LP in March 2008 to explore asset management and advisory opportunities in ChinaIndia and other markets. Origo and GLG Partners LP have also entered into an agreement whereby Origo will provide GLG Partners LP research services for a period of three years for a fee of £3 million.

On its admission to AIM in December 2006 Origo raised GBP12.8 million gross of new money via a placing of 25,673,238 Ordinary Shares at 50 pence per share. Each ordinary share carried a warrant exercisable at 55p. 

Origo has a significant portfolio of investments in a range of industrial sectors, including mobile applications and content; natural resources; art and paper products; furniture; food and beverage; online gaming; anti-virus software; and bio energy. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCILFILDDITLIT
Date   Source Headline
30th May 20227:00 amRNSCancellation - Origo Partners Plc
27th May 20226:00 pmRNSOrigo Partners
28th Apr 20227:30 amRNSSuspension – Origo Partners plc
26th Apr 20227:00 amRNSSuspension from Trading
7th Mar 20227:00 amRNSAsset Sale Update
2nd Feb 20227:00 amRNSReturn of Capital and Asset Sale
27th Jan 20223:16 pmRNSAsset Sale
24th Dec 202110:46 amRNSResult of AGM
6th Dec 20213:34 pmRNSNotice of AGM
3rd Dec 20217:00 amRNSInvestment Update
22nd Sep 20217:00 amRNSHalf-year Report
28th Jun 20217:00 amRNSAnnual Financial Report
4th Jun 20217:00 amRNSSale of Shares in Gobi Coal & Energy Ltd
14th May 202111:18 amRNSHolding(s) in Company
9th Mar 202112:20 pmRNSHolding(s) in Company
8th Mar 20217:00 amRNSStatement re share price movement
24th Feb 20214:27 pmRNSHolding(s) in Company
23rd Feb 20219:53 amRNSHolding(s) in Company
27th Jan 20218:38 amRNSUpdate re Website
22nd Jan 202110:03 amRNSUpdate re Remaining Assets
24th Dec 202011:20 amRNSResult of AGM
24th Dec 202010:14 amRNSHolding(s) in Company
24th Dec 20209:51 amRNSHolding(s) in Company
17th Dec 202012:38 pmRNSHolding(s) in Company
30th Nov 20204:30 pmRNSNotice of AGM
28th Sep 20207:00 amRNSHalf-year Report
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:02 amRNSSecond Price Monitoring Extn
22nd Sep 20202:06 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:01 pmRNSPrice Monitoring Extension
30th Jun 20207:00 amRNSAnnual Financial Report
12th Jun 20207:00 amRNSInvestment update
20th May 202011:00 amRNSHolding(s) in Company
7th May 20207:00 amRNSUpdate RE: Liquidation Plans
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:02 pmRNSPrice Monitoring Extension
17th Mar 202012:12 pmRNSChange of Registered Office & Update on Website
12th Mar 20203:32 pmRNSWebsite
4th Feb 20207:00 amRNSInvestment Update
24th Dec 20197:00 amRNSInvestors update
11th Nov 201911:33 amRNSHolding(s) in Company
30th Oct 20194:16 pmRNSResult of AGM
23rd Oct 201910:41 amRNSHolding(s) in Company
23rd Oct 201910:39 amRNSHolding(s) in Company
4th Oct 20194:23 pmRNSNotice of AGM
27th Sep 20194:25 pmRNSReplacement Capital Distribution
27th Sep 201911:05 amRNSReplacement Interim Unaudited Financial Statements
27th Sep 20197:05 amRNSCapital Distribution
27th Sep 20197:00 amRNSInterim Unaudited Financial Statements
28th Jun 20194:15 pmRNSPosting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.